Latest Financials News

KKR Credit Income Fund reported a slight dip in net assets for FY2025 but upheld its monthly distributions and reinstated its distribution reinvestment plan, navigating currency headwinds with active hedging.

Clime Capital Limited reported a $3.06 million net profit for FY25 and announced a 1.35 cent dividend, while restructuring its convertible notes to enhance investor returns.

Clime Capital Limited reported a 29% drop in net profit for FY25 but maintained its quarterly dividends and rolled over convertible notes with enhanced terms. The company is pivoting towards a debt-focused portfolio to boost income stability.

Embelton Limited reports a notable decline in revenue and profit for FY2025 amid a challenging construction market, yet maintains its dividend payout, signaling cautious optimism.

The Australian Wealth Advisors Group Ltd (AWAG) reported a 13% revenue increase and a $1.2 million profit before tax in FY2025, driven by strategic Equity Partnership Scheme investments and a strong funds under management base.

The Australian Wealth Advisors Group Ltd (AWAG) reported a $1.18 million net profit before tax in its first full year as an ASX-listed company, reversing a prior loss and growing revenue by 13%. The company expanded its funds under management and equity investments, positioning itself for further industry consolidation.

Imperial Pacific Limited has announced a fully franked ordinary dividend of AUD 0.07 per share for the fiscal year ending June 2025, alongside a Dividend Reinvestment Plan to offer shareholders flexible options.

Desane Group Holdings Limited reported a strong FY25 with net profit after tax doubling to $3.3 million, supported by a $6.2 million uplift in property valuations and key lease extensions securing future rental income.

Asset Vision reported robust FY25 results with significant revenue and cash flow growth, achieving a debt-free status while advancing its AI-powered asset management platform.

Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

PolyNovo Limited reported a robust 28.9% increase in group sales to A$118.6 million for FY25, alongside a 151% surge in net profit after tax to A$13.2 million, driven by strong U.S. growth and key regulatory approvals.